Craneware (LON:CRW) Given “Buy” Rating at Shore Capital

Shore Capital reissued their buy rating on shares of Craneware (LON:CRW) in a report issued on Tuesday morning, Marketbeat Ratings reports. Shore Capital currently has a GBX 2,850 price objective on the stock.

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 2,900 price objective on shares of Craneware in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of GBX 2,873.67.

Craneware Price Performance

Shares of LON:CRW opened at GBX 1,835 on Tuesday. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63. The firm has a fifty day moving average price of GBX 1,988.31 and a 200 day moving average price of GBX 2,185.43. Craneware has a fifty-two week low of GBX 1,330 and a fifty-two week high of GBX 2,644. The firm has a market cap of £651.59 million, a price-to-earnings ratio of 33.24 and a beta of 0.28.

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.